跳至主要内容
临床试验/EUCTR2007-006671-36-ES
EUCTR2007-006671-36-ES进行中(未招募)不适用

Protección miocárdica durante la reperfusión en pacientes con síndrome coronario agudo con elevación del segmento ST sometidos a angioplastia primaria: efecto de la adenosina intracoronaria sobre el tamaño del infarto y el remodelado ventricular.Myocardial protection during reperfusion in patients with acute coronary syndrome with ST segment elevation submitted to prymary angioplasty: effect of intracoronary adenosine on infaract size and remodeling. - PROMISE

VALLE HEBRON HOSPITA0 个研究点开始时间: 2008年1月28日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - PATIENTS OLDER THAN 18.
  • - PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION WITHIN SIX HOURS OF THE ONSET OF SYMPTOMS.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - PATIENTS YOUNGER THAN 18 AND PREGNANT WOMEN.
  • - PATIENTS WITH PREVIOUS TRANSMURAL INFARCT.
  • - PATIENTS WITH CLINICAL EVIDENCE OF BRONCHOSPASTIC LUNG SISEASE OR PRIOR BRONCHODILATOR THERAPY.
  • - PATIENTS WITH PACEMAKERS.
  • - PATIENTS PRESENTING TIMI FLOW BETWEEN 3 AND 1.

研究者

发起方
VALLE HEBRON HOSPITA

相似试验